Callan Family Office’s Cognizant CTSH Stock Holding History

Callan Family Office’s Portfolio CTSH Stock Details CTSH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.92M	Buy	31,222 +10,699	+52%	+$766K	0.04%	369
2025 Q4	$1.7M	Buy	20,523 +15,597	+317%	+$1.17M	0.04%	390
2025 Q3	$330K	Sell	4,926 -127	-3%	-$9.18K	0.01%	671
2025 Q2	$394K	Buy	+5,053	New	+$387K	0.01%	684

Other funds holding CTSH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Callan Family Office's CTSH Position: Q1 2026 in Review

Callan Family Office increased its Cognizant (CTSH) stake by 52% in Q1 2026, buying an estimated $766K and bringing the position to 31,222 shares worth $1.92M. The position accounts for 0.04% of the portfolio, ranked #369.

Callan Family Office first reported a position in CTSH in Q2 2025 and has held it in 4 quarters since. 985 funds tracked by Wall St. Rank hold CTSH as of Q1 2026.

Callan Family Office held 31,222 shares of Cognizant worth $1.92M as of Q1 2026.
Callan Family Office bought 10,699 Cognizant shares in Q1 2026, an estimated $766K.
Cognizant made up 0.04% of Callan Family Office's portfolio in Q1 2026, its #369 holding.
Callan Family Office first reported a position in Cognizant in Q2 2025 and has held it in 4 quarters since.
985 funds tracked by Wall St. Rank held Cognizant as of Q1 2026.

Based on Callan Family Office's 13F filing for Q1 2026, filed 13 May 2026.